|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Effect of reduction and partial replacement of sodium on bologna characteristics and acceptability 显示文摘 | Seman D L Olson D G Mandigo R W | 1980 | J Food Sci1980，45，： | 1 |
| 2 | Lipoprotein(a),homocysteine,and remnantlike particles:emerging risk factors显示文摘 | SEMAN L J McNAMARA J R SCHAEFER E J | 1999 | Curr Opin Cardiol1999，14，： | 1 |
| 3 | Population pharmaco- kinetics of empagliflozin, a sodium glucose cotransporter 2 inhibi- tor, in patients with type 2 disabetes 显示文摘 | RIGGS M M STAAB A SEMAN L | 2013 | J Clin Pharmacol2013，53，10： | 1 |
| 4 | Effect of reduction and partial replaement of sodium on bologna characteristics and acceptability显示文摘 | Seman D L Olson D G | 1980 | Journal of Food Science1980，，： | 1 |
| 5 | Lp(a)cholesterol and coronary heart disease in the Framingham heart study显示文摘 | SEMAN L J DELUCA C TENNER J L | 1999 | Cin Chem1999，45，7： | 1 |
| 6 | Safety, tolerability, pharmacokineties, and pharmacodynamics of multiple rising doses of empagliflozin in patients with type 2 diabetes mellitus显示文摘 | HEISE T SEMAN L MACHA S | 2013 | Dia- betes Therapy2013，4，2： | 1 |
| 7 | A phase IIb, randomized, placebo-controlled study of the SGLT2 inhibitor empagliflozin in patients with type 2 diabetes 显示文摘 | FERRANNINI E SEMAN L SEEWALD-BECKER E | 2013 | Diabetes Obes Metab2013，15，8： | 1 |
| 8 | A Phase lib,randomized, placebo-controlled stndy of the SGLT2 inhibitorempagliflozin in patients with type 2 diabetes 显示文摘 | Ferrannini E Seman L Seewaldt-Becker E | 2013 | DiabetesObes Metab2013，15，8： | 1 |
| 9 | Atmospheric sulfur and deep convective clouds in tropical Pacific: A model study 显示文摘 | Andronache C Donner L J Seman C J | 1999 | Geophys Res1999，104，： | 1 |
| 10 | Safety, tolerability, pharmacokinetics and pharmacodynam- ics of single doses of empagliflozin, a sodium glu- cose cotransporter 2 (SGLT2) inhibitor, in healthy Japanese subjects 显示文摘 | Sarashina A Koiwai K Seman L J | 2013 | Drug Metab Pharmacokinet2013，28，3： | 1 |
| 11 | Lipoprotein(a)-choles-terol and coronary heart disease in the Framingham Heart Study显示文摘 | Seman L Deluca C Jenner J | 1999 | Clin Chem1999，，： | 1 |
| 12 | Safety, tolerability, pharmacokinetics and pharmacodynam- ies of single doses of empagliflozin, a sodium glu- cose cotransporter 2 (SGLT2) inhibitor, in healthy Japanese subjects 显示文摘 | Sarashina A Koiwai K Seman L J | 2013 | Drug Metab Pharmacokinet2013，28，3： | 1 |
| 13 | Laparovaginal hysterec- tomy: a decade of evolution显示文摘 | Cook J R O'Shea R T Seman E L | 2004 | Aust N Z J Obstet Gynecol2004，44，： | 1 |
| 14 | Creating a therapeutic milieu in dementia care显示文摘 | Taft L Delaney K Seman D | 1993 | J of Gerontologist Nursing1993，19，10： | 1 |
| 15 | Influence of packaging method and length of chilled storage on microflora, tenderness and colour stability of venison loins 显示文摘 | Dennis L Seman Ken R Drew Paul A Clarken Roger P Littlejohn | 1988 | Meat Science1988，22，4： | 1 |
| 16 | Spring-back simulation of unidirectional carbon/epoxy flat laminate com- posite manufactured through autoclave process显示文摘 | MEZEIX L SEMAN A NASIR M N M | 2015 | Compos ite Structures2015，124，： | 1 |
| 17 | Safety, tolerability, pharmacokinetics and pharmacodynamics of single doses of empagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, in healthy Japanese subjects 显示文摘 | Sarashina A Koiwai K Seman L J | 2013 | Drug Metab Pharmacokinet2013，28，3： | 1 |
| 18 | A Phase IIb, randomized, placebo-controlled study of the SGLT2 inhibitor empagliflozin in patients with type 2 diabetes 显示文摘 | Ferrannini E Seman L Seewaldt-Becker E | 2013 | Diabetes Obes Metab2013，15，8： | 1 |
| 19 | Analysis of muhi-land high pressure oil seals显示文摘 | Semanate J E Andres L S | 1993 | S T L E Tribology Transactions1993，36，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员